Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 18:15:1490855.
doi: 10.3389/fmicb.2024.1490855. eCollection 2024.

Spinal cord injury: pathophysiology, possible treatments and the role of the gut microbiota

Affiliations
Review

Spinal cord injury: pathophysiology, possible treatments and the role of the gut microbiota

Luis H Pagan-Rivera et al. Front Microbiol. .

Abstract

Spinal cord injury (SCI) is a devastating pathological state causing motor, sensory, and autonomic dysfunction. To date, SCI remains without viable treatment for its patients. After the injury, molecular events centered at the lesion epicenter create a non-permissive environment for cell survival and regeneration. This newly hostile setting is characterized by necrosis, inflammation, demyelination, axotomy, apoptosis, and gliosis, among other events that limit locomotor recovery. This review provides an overview of the pathophysiology of SCI, highlighting the potential role of the gut microbiota in modulating the inflammatory response and influencing neurological recovery following trauma to the spinal cord. Emphasis on the bidirectional communication between the gut and central nervous system, known as the gut-brain axis is given. After trauma, the gut-brain/spinal cord axis promotes the production of pro-inflammatory metabolites that provide a non-permissive environment for cell survival and locomotor recovery. Therefore, any possible pharmacological treatment, including antibiotics and painkillers, must consider their effects on microbiome dysbiosis to promote cell survival, regeneration, and behavioral improvement. Overall, this review provides valuable insights into the pathophysiology of SCI and the evolving understanding of the role of the gut microbiota in SCI, with implications for future research and clinical practice.

Keywords: dysbiosis; gut microbiome; gut-brain axis; neurodegenerative; spinal cord trauma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Spinal cord injury progression. (A) Healthy spinal cord consisting of multiple neuronal cells. (B) Primary phase caused by trauma to the spinal cord, resulting in necrosis, axotomy, hemorrhage, edema, and immune cells infiltration that promotes inflammation. (C) Secondary phase is characterized by astrogliosis and the formation of the glial scar, demyelination and apoptosis, with the continuous inflammatory response. Created in BioRender. Pagan (2024) https://BioRender.com/r98w142.
Figure 2
Figure 2
Simplified representation of spinal cord injury, resulting in the disruption of preganglionic and postganglionic neurons communication, causing the loss of neural input over the gastrointestinal tract. The end-result is a change in the microbiota profiles resulting in dysbiosis and inflammation. Created in BioRender. Pagan (2024) https://BioRender.com/a13d580.
Figure 3
Figure 3
Mechanisms by which the gut microbiome can metabolize internalized drugs. (a) Enzymes synthesized by the microbes metabolize the drugs through multiple biochemical reactions such as hydrolysis and functional group transfer. (b) Microbial metabolites interact with host receptors, triggering complex signaling pathways that influence drug response and therapeutic outcomes. Created in BioRender. Pagan, L. (2024) https://BioRender.com/z34y623.

Similar articles

Cited by

References

    1. Abbott N. J., Patabendige A. A. K., Dolman D. E. M., Yusof S. R., Begley D. J. (2010). Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13–25. doi: 10.1016/j.nbd.2009.07.030 - DOI - PubMed
    1. Afshari K., Momeni Roudsari N., Lashgari N. A., Haddadi N. S., Haj-Mirzaian A., Hassan Nejad M., et al. . (2021). Antibiotics with therapeutic effects on spinal cord injury: a review. Fundam. Clin. Pharmacol. 35, 277–304. doi: 10.1111/fcp.12605, PMID: - DOI - PubMed
    1. Ahuja C. S., Wilson J. R., Nori S., Kotter M. R. N., Druschel C., Curt A., et al. . (2017). Traumatic spinal cord injury. Nat. Rev. Dis. Primers 3:18. doi: 10.1038/nrdp.2017.18 - DOI - PubMed
    1. Al Bander Z., Nitert M. D., Mousa A., Naderpoor N. (2020). The gut microbiota and inflammation: an overview. Int. J. Environ. Res. Public Health 17:618. doi: 10.3390/ijerph17207618, PMID: - DOI - PMC - PubMed
    1. Alizadeh A., Dyck S. M., Karimi-Abdolrezaee S. (2019). Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front. Neurol. 10:282. doi: 10.3389/fneur.2019.00282, PMID: - DOI - PMC - PubMed

LinkOut - more resources